SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-γ, and Point Mutation in the Transcription Intermediary Factor 1-γ Coding Gene: A Case Report-Reference-Cited by-同舟云学术

SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-γ, and Point Mutation in the Transcription Intermediary Factor 1-γ Coding Gene: A Case Report

Published:2021-09 Issue:9 Volume:2 Page:100217
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Arnon Johnathan,Elia Anna,Nevo Yuval,Lossos Alexander,Nechushtan Hovav

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference5 articles.

1. Paraneoplastic syndromes associated with small cell lung cancer;Gandhi;JNCCN J Natl Compr Cancer Netw,2006

2. Dermatomyositis associated with lung neuroendocrine carcinoma;Takashima;Intern Med,2017

3. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study;András;J Rheumatol,2008

4. Anti-TIF1-γautoantibodies: warning lights of a tumour autoantigen;De Vooght;Rheumatology (Oxford),2020

5. The roles of TIF1γ in cancer;Yu;Front Oncol,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis of immunotherapy responses in small cell lung cancer patients with dermatomyositis;Thoracic Cancer;2024-02-14

2. Two cases of dermatomyositis associated with neuroendocrine tumors;International Cancer Conference Journal;2023-08-31

3. Dermatomyositis Associated with Lung Cancer: A Brief Review of the Current Literature and Retrospective Single Institution Experience;Life;2022-12-23

4. Immune checkpoint inhibitor therapy in a patient with small cell lung cancer and anti‐transcriptional intermediary factor 1‐γ antibody‐positive dermatomyositis: A case report;Thoracic Cancer;2022-08-18